Southeast BIO 2018

Southeast BIO Investor & Partnering Forum

Mark your calendar to attend the region’s premiere life sciences and medical technology conference connecting emerging companies with potential investors and corporate partners. Celebrating its 20th anniversary, the Southeast BIO Investor & Partnering Forum returns to Atlanta on November 13-14 with a new format, new networking opportunities, and new investment prospects.

The SEBIO Forum features:

  • Executives, entrepreneurs, venture capitalists, investment bankers, angel investors, university representatives, and other industry professionals from across the Southeast and Eastern U.S.
  • Presentations from the region’s most promising life science and medtech companies
  • The ability to arrange one-on-one meetings through the SEBIO Connect online partnering system
  • World-class speakers and panels featuring engaging conversations by industry leaders
  • Corporate Partnering – hear from senior executives about partnering approaches and strategic areas of interest

... and more!

Bookmark the conference webpage to stay up-to-date on the Forum including announcements on the program, registration, and details on exclusive networking.

Agenda

Tuesday, November 13, 2018

  • 8:00am – 3:00pm – Investor Golf Event (invitation only)
  • 9:00am – 7:00pm – Registration
  • 9:00am – 6:00pm – SEBIO Connect
  • 2:30pm – 5:00pm – Capitalize Mentoring
  • 5:00pm – 6:30pm – Board of Directors Meeting  (invitation only)
  • 6:30pm – 8:00pm – Kick-Off Reception
  • 7:30pm – 9:30pm – Investor Dinner (invitation only)

Wednesday, November 14, 2018

  • 7:00am – 8:00am – Yoga
  • 7:00am – 5:00pm – Registration
  • 8:00am – 6:00pm – SEBIO Connect (see event app for appointment times and locations)
  • 8:00am – 8:30am – Continental and Connecting
  • 8:30am – 9:30am – Early Stage Investing: And We Mean Early
    • Bob Creeden, Managing Director, UVA LVG Seed Fund & New Ventures
    • Bob Crutchfield, Managing Director, BrightEdge Ventures
    • Dennis Liotta, Ph.D, Executive Director, Emory Institute for Drug Development
    • Alan Bentley, Assistant Vice Chancellor, Vanderbilt Center for Technology Transfer & Commercialization
  • 9:45am – 10:45am
    • Corporate Venture Capital Panel
      • Steve Hall, Ph.D., General Partner, Lilly Ventures (Moderator)
      • Gladys Nunez, Principal, Amgen Ventures
      • Charles Kunsch, Ventures Director, Abbvie Ventures
      •  Linda Lohr, Portfolio Strategist, Pfizer
  • 10:45am– 11:00am – Coffee and Connecting
  • 11:00am – 11:45am – Company Presentations
    • Concert Genetics
    • Cavion, Inc.
    • NeuroTonik, Inc.
  • 11:45am– 12:15pm – Coffee and Connecting
  • 12:15pm – 1:45pm – Awards Luncheon & Keynote
    • Keynote Address – Jeff Arnold, Chairman and CEO, Sharecare
  • 1:45pm– 2:00pm – Coffee and Connecting
  • 2:00pm– 2:45pm – Company Presentations
    • Spyryx Biosciences
    • AKESOgen
    • Celtaxys
  • 2:45pm – 3:00pm – Networking Break
  • 3:00pm – 4:00pm – Neurosciences – 20 Years Later – A Conversation
    • Max Wallace, Chief Executive Officer, Accelerating Brain Cancer Cure
      (Conversation Leader)
    • Dr. Teo Dagi, MD, General Partner, HLM Venture Partners
  • 3:00pm – 4:00pm – The Future of the Medical Device Industry
    • Scott Weiner, Partner, Pappas Ventures (Moderator)
    • Jed Cohen, Managing Director, Leerink
    • Justin Klein, Partner, NEA
    • Timothy Patrick, President, Chief Executive Officer and Co-Founder of Cartiva
    • Peter Shagory, Executive Vice President, CONMED Corporation
  • 4:00pm – 5:00pm – Wine Reception
  • 5:00pm – 6:00pm – Early Stage Shootout & Closing
    • Doug Gooding, Knowles IP Strategies (Host)
  • 6:00pm – 7:30pm – Gala Reception + Early Stage Shootout Winners Announced

More Information

For questions, or to get more information on presenting or sponsoring, please email David Day.

Congratulations to the six North Carolina companies that are finalists for awards. Learn more about these finalists.

-

Loews Atlanta Hotel
1065 Peachtree St. NW
Atlanta, GA 30309

$649-$749
Agriculture Biomanufacturing Human Therapeutics Marine Biotech Medical Devices Precision Health